Other UTD-affiliated study authors included Dr. Jane Wigginton, medical director and co-director of the UT Dallas Clinical and Translational Research Center; Amy Porter MBA20, TxBDC director of operations; and Holle Carey Gallaway MBA23, TxBDC research biomedical engineer.